BNET Industries
Last Fiscal Year Sales:$246.3M
- Public
- CA
Dow Jones Description
Developer, Mfr & Marketer of Optical Imaging Products
President & CEO
Sebastien GignacNumber of Employees 64
Peer Companies
NAICS Code Analytical Laboratory Instrument Manufacturing: 334516
Recent Events
-
ART Advanced Research Technologies Inc. Announces Unanimous Support in Favour of Its Proposal to Creditors
-
Medical device company ART reaches restructuring proposal after review
-
ART Advanced Research Reveals Restructuring Agreement And Proposal To Creditors - Quick Facts
-
ART Advanced Research Technologies Launches Optix MX3 Molecular Imaging System at WMIC2009
News & Analysis
Filter by
art advanced research technologies inc. and oppenheimerfunds inc. - All News and Analysis
ART Announces Closing of Additional $2.3 Million Investment by OppenheimerFunds, Inc. Through Exercise of Option.
MONTREAL, CANADA, Apr 25, 2006 CCNMatthews via COMTEX -- Funding to be used by ART as working capital and to finance corporate development. THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES...
ART Announces Additional $2.3 Million Investment by OppenheimerFunds, Inc. Through Exercise of Option.
MONTREAL, CANADA, Apr 19, 2006 CCNMatthews via COMTEX -- OppenheimerFunds to invest $2,280,000 in consideration for an additional 2,000,000 preferred shares of ART Advanced Research Technologies Inc. under terms of 2005 private placement. THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND...
ART Advanced Research Technologies Inc. Announces Closing of Private Placement of US$5.9 Million With OppenheimerFunds, Inc.
MONTREAL, QUEBEC, Jul 14, 2005 CCNMatthews via COMTEX THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A...
OppenheimerFunds, Inc. to Invest an Additional US$5.9 Million in ART Advanced Research Technologies Inc., Financing Represents Fourth Investment in ART by OppenheimerFunds Since 2001.
MONTREAL, CANADA, Jul 11, 2005 CCNMatthews via COMTEX THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Sebastien Gignac | President & CEO |
| Jacques Bedard | CFO |
| Joe Kozikowski | Chief Medical Officer |
| Warren G. Baker | COO |
| Mario Khayat | Vice President, Optical Products |
| Pierre Couture | Vice President, Sales & Marketing |
| Andreas Mirow | Marketing Manager, Product |
| Carlos Marques | General Manager, Product |
| Dr Amir H Gandjbakhche | |
| Dr Daniel B Kopans | |
| Dr David Boas | |
| Dr Irving J Bigio | |
| Dr Joseph Lakowicz | |
| Dr Martin Yaffe | |
| Jacques B E dard | |
| S E bastien Gignac | |
| Samuel Achilefu | |
| William Webb |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Benoit La Salle | Chairman |
| George N Fugelsang | Board of Directors |
| Jacques Courville | Board of Directors |
| Pierre Dutheil | Board of Directors |
| Raymond Cyr | Board of Directors |
| Rierre Dutheil | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | President & CEO | Current |
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
| ART Advanced Research Technologies, Inc. | General Counsel & Secretary | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | CFO | Current |
| Organization | Position | Status |
|---|---|---|
| Clinivation, Inc. | President & CEO | Current |
| ART Advanced Research Technologies, Inc. | Chief Medical Officer | Current |
| Proformant, Inc. | Chairman and Managing Partner of Proformant | Current |
| Proformant, Inc. | CEO | Former |
| Massachusetts Gen Hospital | Principal Investigator | Former |
| Massachusetts General Hospital | Principal Investigator | Former |
| Johnson & Johnson | Former | |
| Biogen, Inc. | Former | |
| Rigid Building Systems Ltd. | Former | |
| Mallinckrodt Inc. | Former | |
| Villanova University | Former | |
| Johns Hopkins University School of Medicine | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | COO | Current |
| Hewlett-Packard Company | program manager | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Vice President, Optical Products | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Vice President, Sales & Marketing | Current |
| Mallinckrodt Inc. | Former | |
| Tyco International Ltd. | Former | |
| McGill University | Advanced Management Course for Senior Executives | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Marketing Manager, Product | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | General Manager, Product | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current | |
| Harvard Medical School | Assistant Professor | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current | |
| Microsoft Corporation | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current | |
| McGill University | degrees in civil and common law | Former |
| Organization | Position | Status |
|---|---|---|
| Washington University School of Medicine | Associate Professor of Radiology | Current |
| ART Advanced Research Technologies, Inc. | Current | |
| Customized Therapeutics LLC | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| SEMAFO, Inc. | President and CEO | Current |
| Pebercan Inc. | Chairman | Current |
| Afcan Mining Corp | Chairman | Current |
| ART Advanced Research Technologies, Inc. | Chairman | Current |
| LMS Medical Systems Inc. | Board of Directors | Current |
| SEMAFO, Inc. | Chairman and CEO | Former |
| LMS Medical Systems Inc. | Chairman | Current |
| Associes | Founder | Former |
| Vasogen, Inc. | Chairman | Former |
| ART Advanced Research Technologies, Inc. | Board of Directors | Former |
| Pebercan Inc. | Board of Directors | Former |
| SEMAFO, Inc. | Board of Directors | Former |
| McGill University | Masters of Business Administration from Imede, Switzerland. | Former |
| McGill University | bachelor's degree in business | Former |
| McGill University | Degree | Former |
George Fugelsang is the former Chief Executive Officer of Dresdner Kleinwort Benson North America, former Chairman of the Board of Dresdner Bank Mexico, S.A., former Chairman of the Board of Dresdner Bank Canada, and a member of the Board of Dresdner RCM Global Investors LLC. Prior to joining the Dresdner family, Mr. Fugelsang served as the Managing Director in Morgan Stanley s Investment Banking Division in London and spent more than twenty years at Citicorp/Citibank in various positions throughout the United States, Latin America, and Central, Southern, and Eastern Europe. Mr. Fugelsang serves as Deputy Chairman of the Board of Trustees of the Institute of International Bankers, and is a member of the Board of Trustees of Thunderbird (the American Graduate School of International Management) and the Board of Trustees of the Arthur F. Burns Fellowship. He is also a member of the Board of the German American Chamber of Commerce, Inc. and a Fellow of the Foreign Policy Association of New York. He graduated from the University of Oregon in 1962 with a dual major in Economics and Political Science. He continued his studies, pursuing a degree in foreign trade at the American Graduate School of International Management in Phoenix, Arizona, where he graduated with honors as the class valedictorian in 1963.
| Organization | Position | Status |
|---|---|---|
| Energy Investors Funds Group, LLC | Board of Directors | Current |
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
| Birdsong Medical Devices | Advisory Board Member | Current |
| Dresdner Kleinwort Benson | President | Former |
| Dresdner Kleinwort Benson | Chief Executive | Former |
| Morgan Stanley | Managing Director | Former |
| Dresdner Kleinwort Wasserstein | Co-Chairman | Former |
| University of Oregon | B.S. Degree In Political Science | Former |
| American Graduate School of International Management | degree in foreign trade | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
| University of Oslo | Doctorate in Neuroanatomy | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
| ACE Aviation Holdings Inc. | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
Executive News
-
ART Advanced Research Technologies Announces Second Quarter 2009 Financial Results Conference Call
| Volume | 965,003 |
| Shares Outstanding | 0. |
| Market Cap | 0. |
| Year High | 22.31 |
| Year Low | 3.87 |
| Earnings Per Share | -0.859317 |
| P/E Ratio | N/A |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Hansen Medical, Inc. Q3 2009 Earnings Call Transcript
on Dec 18, 2009about HNSN
-
Synergetics USA, Inc. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about SURG
-
Cantel Medical Corp. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 09, 2009about CMN
-
The Cooper Companies, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about COO
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT


